Elektrofi Stock

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.

Sign up today and learn more about Elektrofi Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Elektrofi Stock

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience. Elektrofi’s formulation system can effectively process a wide range of therapeutic molecules. Their technology has the capacity to process large, increasingly complex and delicate proteins including monoclonal antibodies, bispecifics and fusion proteins. Founded in 2016, Elektrofi is based in Boston, Massachusetts, United States.

Funding History

June 2017$225K
September 2018$1.6M
June 2022$40.0M

Management

Co-founder, CEO

Chase Coffman

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo